Ignite Creation Date:
2024-05-05 @ 4:58 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00350090
Status:
TERMINATED
Last Update Posted:
2011-05-19
First Post:
2006-07-07
Brief Title:
A Study to Assess the Response Rate of PROCRIT Epoetin Alfa Given at a Dose of 40000 Units Once a Week to Cancer Patients With Anemia Who Are Not Receiving Chemotherapy
Sponsor:
Ortho Biotech Products LP
Organization:
Ortho Biotech Products LP
Organization Data
Organization:
Ortho Biotech Products LP
Class:
INDUSTRY
Study ID:
CR005113
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ortho Biotech Products LP
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None